Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 404
Selected: 0
NCT IDTitle
NCT01011010Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
NCT02191982The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older
NCT03672318Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma
NCT03176082Mailed Reminders Plus Fecal Immunochemical Testing
NCT00099008Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
NCT02130947Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
NCT00776126Digital Breast Tomosynthesis Preference Study
NCT04974489Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes
NCT00088985Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer
NCT00280735Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC
NCT00280150Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
NCT01000883Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT06090864ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
NCT03077230Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer Screening
NCT05542407ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
NCT00520000Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors
NCT03196037Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors
NCT02043470Retinal Oxygen Function After Radiation Therapy
NCT03161834Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
NCT07278557Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia
NCT00764322Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen
NCT02449837Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy
NCT02577939Evaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell Transplantation
NCT05755347Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer
NCT06902311Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
NCT01759355Hybrid PET/MR in the Therapy of Cervical Cancer
NCT01725048Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer
NCT04142554Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast Cancer
NCT01969370NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
NCT01208662Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
NCT03862105Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer
NCT05720546Young Adult Infusion Space Experience Satisfaction Survey
NCT03978624Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
NCT00266097Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
NCT00280176Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer
NCT03160209HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi
NCT00334438Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma
NCT04670068Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
NCT00283244Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC
NCT02138617Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
NCT06902376XL092 and Cemiplimab in BRAF WT Thyroid Cancer
NCT02574897The Ability of Electronic Patient Symptom Reporting to Reduce Symptom Burden During Hospitalization for Chemotherapy
NCT01361113Neoadjuvant Pazopanib in Renal Cell Carcinoma
NCT03544268Academic-Industrial Partnership for Translation of Acoustic Angiography
NCT00405366Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer
NCT04931251Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings
NCT06158139Autologous CAR-T Cells Targeting B7-H3 in PDAC
NCT01560663Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
NCT02111616Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study
NCT02003430Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers